Division of Infectious Diseases, Mayo Clinic, Rochester, MN.
Division of Infectious Diseases, Mayo Clinic, Rochester, MN; Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, MN.
Mayo Clin Proc. 2019 Sep;94(9):1781-1785. doi: 10.1016/j.mayocp.2019.02.020. Epub 2019 Aug 7.
To evaluate the diagnostic yield of fungal smears and cultures from bronchial lavage and wash specimens obtained from immunocompetent patients in the intensive care unit (ICU) because respiratory tract samples from patients in the ICU often undergo extensive microbiological testing.
In total, we enrolled 112 immunocompetent adult patients treated in the medical and surgical ICU between July 1, 2016, and June 30, 2017. We evaluated whether the results of fungal smears and cultures of specimens obtained from bronchoscopy and bronchoalveolar lavage changed patient care.
In total, 131 bronchoscopic specimens and 31 bronchoalveolar lavage specimens were tested for fungi. Cultures were held for an estimated 4680 culture-days. Two results changed patient therapy. In both cases, other routine tests provided the same information as fungal culture before these results were returned.
In immunocompetent, critically ill patients, fungal culture of respiratory tract specimens does not add diagnostic value. Routine fungal culture of respiratory tract specimens should be discouraged in this population.
评估免疫功能正常的重症监护病房(ICU)患者支气管灌洗和冲洗标本的真菌涂片和培养的诊断效果,因为 ICU 患者的呼吸道标本通常需要进行广泛的微生物学检测。
我们共纳入了 2016 年 7 月 1 日至 2017 年 6 月 30 日期间在医学和外科 ICU 接受治疗的 112 例免疫功能正常的成年患者。我们评估了支气管镜检查和支气管肺泡灌洗获得的标本真菌涂片和培养的结果是否改变了患者的治疗。
共检测了 131 个支气管镜标本和 31 个支气管肺泡灌洗标本进行真菌检测。培养估计进行了 4680 个培养日。有 2 个结果改变了患者的治疗。在这两种情况下,在这些结果返回之前,其他常规检测提供了与真菌培养相同的信息。
在免疫功能正常的重症患者中,呼吸道标本的真菌培养并不能增加诊断价值。在该人群中,应不鼓励常规进行呼吸道标本的真菌培养。